Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.204
Filter
1.
Medicina UPB ; 41(2): 145-156, julio-diciembre 2022. tab, ilus
Article in Spanish | LILACS, COLNAL | ID: biblio-1392156

ABSTRACT

La diabetes mellitus (dm) es una enfermedad crónica con alta incidencia y prevalencia. La enfermedad es un problema de salud pública que ha impulsado a la continua búsqueda de medidas tanto farmacológicas como no farmacológicas para el control. Gracias a la actual evidencia, se sabe que la dm, además de los niveles elevados de glucosa en sangre, se acompaña de otros problemas metabólicos como lo son la obesidad, alteraciones en el metabolismo de lípidos, entre otros; sumado a lo anterior, los pacientes tienen riesgo de padecer problemas cardiovasculares. El problema radica en que una gran cantidad de pacientes con riesgo cardiovascular (CV) o patología cardiovascular ya establecida, sufren de diabetes mellitus. La relación entre dm y las patologías cardiovasculares es de suma importancia, ya que cada una incrementa el riesgo de padecer la otra y empeora el pronóstico. Entre 1980 y 1990 se identificó el cotransportador de sodio y glucosa tipo 2 (SGLT2) como blanco para el tratamiento de la dm tipo 2. A partir de este hallazgo, se crearon los inhibidores de SGLT2 (i- SGLT2), grupo novedoso de medicamentos que disminuyen los niveles de glucosa. Además, tienen múltiples efectos tanto micro como macrovasculares (empagliflozina, canagliflozina y dapagliflozina). Por lo cual, haremos una revisión sobre la evidencia para los iSGLT2 como tratamiento de la insuficiencia cardiaca crónica y su impacto positivo sobre el sistema renal, reducción de presión arterial, disminución de peso, entre otros beneficios.


Diabetes mellitus (dm) is a chronic disease with high incidence and prevalence. The disease is a public health problem that has prompted the continuous search for both pharmacological and non-pharmacological control measures. Thanks to current evidence, it is known that dm, in addition to high blood glucose levels, is accompanied by other metabolic problems such as obesity, alterations in lipid metabolism, among others, and patients are also at risk of suffering from cardiovascular problems. The problema is that a large number of patients with cardiovascular (CV) risk or already established cardiovascular pathology suffer from diabetes mellitus. The relationship between dm and cardiovascular pathologies is extremely important, since each one increases the risk of suffering from the other and worsens the prognosis. Between 1980 and 1990, the sodium-glucose cotransporter 2 (SGLT2) was identified as a target for the treatment of type 2 dm. Based on this finding, SGLT2 inhibitors (i-SGLT2) were created, a novel group of medications that lower glucose levels. In addition, they have multiple effects, both micro and macrovascular (empagliflozin, canagliflozin and dapagliflozin). Therefore, we will review the evidence for iSGLT2 as a treatment for chronic heart failure and its positive impact on the renal system, blood pressure reduction, weight loss, among other benefits.


O diabetes mellitus (dm) é uma doença crônica com alta incidência e prevalência. A doença é um problema de saúde pública que tem motivado a busca contínua por medidas de controle farmacológico e não farmacológico. Graças às evidências atuais, sabe-se que o dm, além dos níveis elevados de glicose no sangue, é acompanhado por outros problemas metabólicos como obesidade, alterações no metabolismo lipídico, entre outros; Além do exposto, os pacientes estão em risco de problemas cardiovasculares. O problema é que um grande número de pacientes com risco cardiovascular (CV) ou patologia cardiovascular já estabelecida sofre de diabetes mellitus. A relação entre dm e patologias cardiovasculares é de extrema importância, pois cada uma aumenta o risco de sofrer uma da outra e piora o prognóstico. Entre 1980 e 1990, o co-transportador sódio-glicose 2 (SGLT2) foi identificado como alvo para o tratamento do dm tipo 2. Com base nessa descoberta, foram criados os inibidores de SGLT2 (i-SGLT2), um novo grupo de drogas que reduzem a glicose níveis. Além disso, eles têm múltiplos efeitos micro e macrovasculares(empagliflozina, canagliflozina e dapagliflozina). Portanto, re-visaremos as evidências do iSGLT2 como tratamento para insuficiência cardíaca crônica e seu impacto positivo no sistema renal, redução da pressão arterial, perda de peso, entre outros benefícios.


Subject(s)
Humans , Diabetes Mellitus , Sodium , Blood Glucose , Weight Loss , Canagliflozin , Sodium-Glucose Transporter 2 Inhibitors , Heart Failure , Obesity
2.
Arq. bras. cardiol ; 118(1): 68-74, jan. 2022. tab
Article in English, Portuguese | LILACS | ID: biblio-1360106

ABSTRACT

Resumo Fundamento Apesar da grande proporção de octogenários com embolia pulmonar aguda, há pouca informação indicando a estratégia de manejo ideal, especialmente medidas terapêuticas, como a terapia lítica. Objetivos O número de pacientes idosos diagnosticados com embolia pulmonar aguda aumenta constantemente. Porém, o papel do tratamento trombolítico não está claramente definido entre os octogenários. Nosso objetivo é avaliar a efetividade da terapia lítica em pacientes octogenários diagnosticados com embolia pulmonar. Métodos Cento e quarenta e oito indivíduos (70,3% de mulheres, n=104) com mais de 80 anos foram incluídos no estudo. Os pacientes foram divididos em dois grupos: tratamento trombolítico versus não-trombolítico. As taxas de mortalidade hospitalar e episódios de sangramento foram definidos como desfechos do estudo. Valor de p <0,05 foi considerado como estatisticamente significativo. Resultados A mortalidade hospitalar reduziu significativamente no grupo trombolítico em comparação ao não-trombolítico (10,5% vs. 24,2%; p=0,03). Episódios de sangramento menores foram mais comuns no braço que recebeu o tratamento trombolítico, mas grandes hemorragias não diferiram entre os grupos (35,1% vs. 13,2%, p<0,01; 7% vs. 5,5% p=0,71, respectivamente). O escore de PESI alto (OR: 1,03 IC95%; 1,01-1,04 p<0,01), a terapia trombolítica (OR: 0,15 IC95%; 0,01-0,25, p< 0,01) e níveis altos de troponina (OR: 1,20 IC95%; 1,01-1,43, p=0,03) estiveram independentemente associados a taxas de mortalidade hospitalar na análise de regressão multivariada. Conclusão A terapia trombolítica esteve associada à mortalidade hospitalar reduzida em detrimento do aumento geral das complicações de sangramento em octogenários.


Abstract Background Despite the high proportion of octogenarians with acute pulmonary embolism, there is little information indicating the optimal management strategy, mainly therapeutic measures, such as lytic therapy. Objectives The number of elderly patients diagnosed with acute pulmonary embolism increases constantly. However, the role of thrombolytic treatment is not clearly defined among octogenarians. Our objective is to evaluate the effectiveness of lytic therapy in octogenarian patients diagnosed with pulmonary embolism. Methods One hundred and forty eight subjects (70.3% women, n=104) aged more than eighty years were included in the study. The patients were divided in two groups: thrombolytic versus non-thrombolytic treatment. In-hospital mortality rates and bleeding events were defined as study outcomes. P-value <0.05 was considered as statistical significance. Results In-hospital mortality decreased significantly in the thrombolytic group compared to the non-thrombolytic group (10.5% vs. 24.2% p=0.03). Minor bleeding events were more common in the arm that received thrombolytic treatment, but major hemorrhage did not differ between the groups (35.1% vs. 13.2%, p<0.01; 7% vs. 5.5% p=0.71, respectively). High PESI score (OR: 1.03 95%CI; 1.01-1.04 p<0.01), thrombolytic therapy (OR: 0.15 95%CI; 0.01-0.25, p< 0.01) and high troponin levels (OR: 1.20 95%CI; 1.01-1.43, p=0.03) were independently associated with in-hospital mortality rates in the multivariate regression analysis. Conclusion Thrombolytic therapy was associated with reduced in-hospital mortality at the expense of increased overall bleeding complications in octogenarians.


Subject(s)
Humans , Child , Adolescent , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Metabolic Syndrome/epidemiology , Pediatric Obesity/therapy , Body Composition , Weight Loss/physiology , Body Mass Index , Atrial Natriuretic Factor/metabolism
3.
Arq. bras. cardiol ; 118(1): 33-40, jan. 2022. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1360114

ABSTRACT

Resumo Fundamento A ação do peptídeo natriurético atrial (ANP) na natriurese, diurese e vasodilatação, resistência à insulina, fígado, rim e tecido adiposo pode contribuir para o desenvolvimento metabólico e cardiovascular saudável. Embora o nível circulante de ANP seja reduzido em pacientes com obesidade, sua resposta à perda de peso ainda é pouco explorada em populações pediátricas. Objetivo Avaliar os efeitos das variações do ANP em resposta à intervenção interdisciplinar para perda de peso na Síndrome Metabólica (SMet) e nos riscos cardiometabólicos em adolescentes com obesidade. Métodos 73 adolescentes com obesidade participaram de uma terapia interdisciplinar para perda de peso de 20 semanas, incluindo uma abordagem clínica, nutricional, psicológica e de exercícios físicos. A composição corporal, análises bioquímicas e pressão sanguínea foram avaliadas. A SMet foi classificada de acordo com a Federação Internacional de Diabetes (IDF) (2007). Após o tratamento, os voluntários foram divididos de acordo com os níveis de plasma do ANP aumento (n=31) ou ANP redução (n=19). Resultados Ambos os grupos apresentaram redução significativa de peso corporal, índice de massa corporal (IMC) e circunferências de cintura, pescoço e quadril (CC, CP e CQ, respectivamente), e aumento da massa livre de gordura (MLG). É interessante observar que houve uma redução significativa na gordura corporal, na razão de TG/HDL-c e na prevalência de SMet (de 23% para 6%) somente no grupo com ANP aumento. Conclusão Este estudo sugere que o aumento nos níveis séricos de ANP após a terapia para perda de peso pode estar associado a melhorias nos riscos cardiometabólicos e na prevalência reduzida de SMet em adolescentes com obesidade.


Abstract Background The action of atrial natriuretic peptide (ANP) on natriuresis, diuresis and vasodilatation, insulin resistance, liver, kidney, and adipose tissue may contribute to the healthy metabolic and cardiovascular development. Even though the circulating level of ANP is reduced in patients with obesity, its response to weight loss remains poorly explored in pediatric populations. Objective To evaluate the effects of ANP variations in response to interdisciplinary weight loss intervention on metabolic syndrome (MetS) and cardiometabolic risks in adolescents with obesity. Methods 73 adolescents with obesity attended a 20-week clinical interdisciplinary weight loss therapy including clinical, nutritional, psychological and exercise training approach. Body composition, biochemical analyses and blood pressure were evaluated. MetS was classified according to the International Diabetes Federation (IDF) (2007). After the treatment, volunteers were divided according to Increasing (n=31) or Decreasing (n=19) ANP plasma levels. Results Both groups present significant reduction of body weight, Body Mass Index (BMI), waist, neck and hip circumferences (WC, NC and HC, respectively) and increasing fat-free mass (FFM). Interestingly, a significant reduction in body fat, TG/HDL-c ratio and MetS prevalence (from 23% to 6%) was observed in the Increased ANP group only. Conclusion This study suggests that an increase in ANP serum levels after weight loss therapy could be associated with improvements in cardiometabolic risks and the reduced prevalence of MetS in adolescents with obesity.


Subject(s)
Humans , Child , Adolescent , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Metabolic Syndrome/epidemiology , Pediatric Obesity/therapy , Body Composition , Weight Loss/physiology , Body Mass Index , Atrial Natriuretic Factor/metabolism
4.
Esc. Anna Nery Rev. Enferm ; 26: e20210375, 2022. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1375398

ABSTRACT

RESUMO Objetivo analisar a relação entre insuficiência familiar e a condição e os marcadores de fragilidade física de idosos acompanhados em ambulatório de Geriatria e Gerontologia. Método estudo quantitativo e transversal realizado com 384 idosos (≥ 60 anos) selecionados por critérios pré-estabelecidos de inclusão e exclusão. Avaliaram-se a fragilidade física segundo o fenótipo da fragilidade e a insuficiência familiar pelo APGAR de Família. Analisaram-se os dados mediante a estatística descritiva e a análise univariada mediante o teste de qui-quadrado com nível de significância estatístico de p≤0,05. Resultados não houve associação entre insuficiência familiar e fragilidade física (p=0,344), entretanto, observou-se percentual de idosos frágeis com elevada Disfunção Familiar (22,2%) e moderada Disfunção Familiar (19,4%), maior que o observado entre os idosos com boa funcionalidade familiar (12,2%). Entre os idosos frágeis para o marcador "fadiga/exaustão", houve proporcionalidade direta ao grau de Disfunção Familiar e relação estatisticamente significativa ao escore total do APGAR de Família (p=0,001). Conclusão e implicações para a prática a insuficiência familiar no idoso está relacionada a outros fatores intrafamiliares e não exclusivamente à fragilidade física, no entanto, pode-se afirmar que o grau de fragilidade física entre os idosos é diretamente proporcional ao nível de Disfunção Familiar.


RESUMEN Objetivo analizar la relación entre insuficiencia familiar y la condición y los marcadores de fragilidad física de ancianos acompañados en ambulatorio de Geriatría y Gerontología. Método estudio cuantitativo y transversal realizado con 384 ancianos (≥ 60 años) seleccionados por criterios preestablecidos de inclusión y exclusión. La fragilidad física fue evaluada de acuerdo el fenotipo de la fragilidad y la insuficiencia familiar según el APGAR de Familia. Los datos fueron analizados por estadística descriptiva y el análisis univariada por prueba de chi-cuadrado con nivel de significancia estadístico de p≤0,05. Resultados no hubo asociación entre insuficiencia familiar y fragilidad física (p=0,344), sin embargo, han sido observados ancianos frágiles con elevada Disfunción Familiar (22,2%) y moderada Disfunción Familiar (19,4%), mayor que lo observado entre los ancianos con buena funcionalidad familiar (12,2%). Entre los ancianos frágiles para el marcador "fatiga/agotamiento" hubo proporcionalidad directa al grado de Disfunción Familiar y relación estadísticamente significativa a la puntuación total del APGAR de Familia (p=0,001). Conclusión e implicaciones para la práctica la insuficiencia familiar en el anciano está relacionada a otros factores intrafamiliares y no exclusivamente a la fragilidad física, sin embargo, se puede afirmar que el grado de fragilidad física entre los ancianos es directamente proporcional al nivel de Disfunción Familiar.


ABSTRACT Objective to analyze the relationship between family insufficiency and the condition and the markers of physical frailty of elderly people followed up in a Geriatrics and Gerontology outpatient clinic. Method a quantitative and cross-sectional study conducted with 384 elderly (≥ 60 years) selected by pre-established inclusion and exclusion criteria. Physical frailty was assessed according to the frailty phenotype and family insufficiency by the Family APGAR. Data was analyzed using descriptive statistics and univariate analysis using the chi-square test with a statistical significance level of p≤0.05. Results there was no association between family insufficiency and physical frailty (p=0.344), however, it was observed a percentage of frail elderlies with high Family Dysfunction (22.2%) and moderate Family Dysfunction (19.4%), higher than that observed among the elderly with good family functioning (12.2%). Among the frail elderly for the marker "fatigue/exhaustion", there was a direct proportionality to the degree of Family Dysfunction and a statistically significant relation to the total score of the Family APGAR (p=0.001). Conclusion and implications for the practice family frailty in the elderly is related to other intra-family factors and not exclusively to physical frailty, however, it can be stated that the degree of physical frailty among the elderly is directly proportional to the level of Family Dysfunction.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Family , Health of the Elderly , Frail Elderly , Ambulatory Care , Health Services for the Aged , Socioeconomic Factors , Health Profile , Exercise , Weight Loss , Cross-Sectional Studies , Hand Strength , Fatigue , Walking Speed
5.
Evid. actual. práct. ambul ; 25(2): e006991, 2022. tab
Article in Spanish | LILACS, BINACIS, UNISALUD | ID: biblio-1380295

ABSTRACT

Los regímenes basados en la restricción intermitente de la ingesta de alimentos, como el ayuno intermitente, pueden parecer novedosos pero constituyen en realidad una práctica milenaria. Muchas veces en nuestras consultas como médicos de familia los pacientes con problemas de sobrepeso u obesidad nos preguntan sobre estas prácticas y sus efectos en la salud. A partir de la viñeta clínica de uno de esos pacientes, revisamos la evidencia disponible sobre el tema y encontramos que la restricción intermitente puede ser una intervención eficaz para la disminución de peso, aunque sin diferencias significativas con respecto a la restricción continua. Para otros desenlaces analizados, como el riesgo cardiovascular, la evidencia no es tan clara. Si bien la restricción alimentaria intermitente puede ser una opción útil en para los pacientes que desean disminuir su peso, se necesitan más estudios para determinar la variante más adecuada, su duración óptima, la mejor frecuencia semanal y sus beneficios a largo plazo. (AU)


Intermittent dietary restriction, like intermittent fasting, may seem like a novel diet, but it's actually an age-old practice. Many times in our practice as family physicians, patients with overweight or obesity problems ask us about this practice and its effects on health. From the clinical vignette of one of our patients, we reviewed the available evidence on the subject and found that intermittent dietary restriction could be an effective intervention for weight loss, but without significant differences with respect to continuous caloric restriction. For other outcomes analyzed, such as cardiovascular risk, the evidence is not as clear. Al though intermittent dietary restriction may be a useful option in our patients, more studies are needed to determine which variant is the most appropriate, its optimal duration, weekly frequency, and long-term benefits. (AU)


Subject(s)
Humans , Male , Adult , Fasting , Overweight/diet therapy , Heart Disease Risk Factors , Hypertension/metabolism , Obesity/diet therapy , Weight Loss , Randomized Controlled Trials as Topic , Caloric Restriction/methods , Overweight/metabolism , Food Deprivation , Systematic Reviews as Topic , Obesity/metabolism
6.
Rev. baiana saúde pública ; 45(3,supl.n.esp): 58-65, 28 dec. 2021.
Article in Portuguese | LILACS | ID: biblio-1352328

ABSTRACT

Este artigo consiste em um estudo de caso de paciente do sexo masculino, 40 anos, com diarreia e perda ponderal significativa iniciada sete meses depois da sua admissão no Hospital Geral Roberto Santos. O paciente não apresentava alterações significativas no exame físico e as investigações clínicas e laboratoriais foram inexpressivas. Foram realizados estudos endoscópicos e anatomopatológicos, confirmando o diagnóstico de neoplasia neuroendócrina gástrica. Os achados histopatológicos evidenciaram um tumor bem diferenciado do tipo dois, sendo uma neoplasia rara de bom prognóstico. O paciente foi submetido a gastrectomia segmentar de corpo gástrico e evoluiu com melhora clínica da diarreia. Ele recebeu alta hospitalar e segue em acompanhamento com os serviços de gastroenterologia e endocrinologia.


This study reports the case of a 40-year-old male patient presenting with diarrhea and significant weight loss initiated seven months before admission at the Hospital Geral Roberto Santos. The patient showed no significant changes in the physical examination, and clinical and laboratory investigations were inexpressive. Gastric neuroendocrine neoplasia was diagnosed by endoscopic and anatomopathological studies. Histopathological findings showed a well-differentiated type 2 tumor ­ a rare neoplasm with a good prognosis. The patient underwent segmental gastrectomy of the gastric body, evolving with clinical improvement of diarrhea. He was discharged from the hospital and is being followed by gastroenterology and endocrinology services.


Paciente del sexo masculino, 40 años, con diarrea y pérdida significativa de peso, que inició siete meses después de su ingreso en el Hospital Geral Roberto Santos. El paciente no presentó cambios significativos en la exploración física y las investigaciones clínicas y de laboratorio fueron inexpresivas. Se realizaron estudios endoscópicos y anatomopatológicos que confirmaron el diagnóstico de neoplasia neuroendocrina gástrica. Los hallazgos histopatológicos mostraron un tumor tipo 2 bien diferenciado, que es una neoplasia poco frecuente y de buen pronóstico. El paciente fue sometido a gastrectomía segmentaria del cuerpo gástrico y evolucionó con mejoría clínica de la diarrea. Fue dado de alta del hospital y aún está en seguimiento con los servicios de gastroenterología y endocrinología.


Subject(s)
Weight Loss , Neuroendocrine Tumors , Diarrhea , Research Report , Gastrectomy
7.
Article in Portuguese | LILACS | ID: biblio-1353115

ABSTRACT

A intoxicação por vitamina D era pouco frequente no Brasil até seu crescente uso na última década. Neste artigo relatamos um caso de intoxicação por vitamina D em que houve a prescrição intencional de dose muito superior ao recomendado pela literatura, com a finalidade de prevenir doenças via "modulação hormonal". A paciente em questão, idosa, previamente hígida, foi submetida a um tratamento não regulamentado e sem respaldo científico, que culminou em sintomas como náuseas e vômitos, além de perda de peso, inapetência, poliúria e astenia ao longo dos meses. Através da história e exames laboratoriais foi diagnosticada intoxicação por vitamina D e lesão renal aguda. Após o tratamento houve remissão completa dos sintomas. A "modulação hormonal" é uma prática condenada pelos Conselhos Federais de Medicina e Odontologia e pela Sociedade Brasileira de Endocrinologia e Metabologia. O ato de prescrever é de grande responsabilidade ética e técnica e deve ser embasado em evidências científicas, oferecendo o melhor tratamento possível aos pacientes, seja ele preventivo ou curativo, minimizando riscos e danos, respeitando as recomendações das autoridades competentes. (AU)


Vitamin D poisoning was not frequent in Brazil until its increasing use in the last decade. In this article, we report a case of intoxication by intentional prescription of vitamin D in a much higher dose than the literature recommends, in order to prevent diseases via "hormonal modulation". The case described in this report was an elderly woman, previously healthy patient that was submitted to an unregulated treatment without scientific support, leading to symptoms such as nausea and vomiting, in addition to weight loss, lack of appetite, polyuria and asthenia over the months. Through the history and laboratory testing, vitamin D intoxication and acute kidney injury were diagnosed. After treatment, there was a complete remission of the symptoms. "Hormonal modulation" is a practice condemned by the Federal Councils of Medicine and Dentistry and by the Brazilian Society of Endocrinology and Metabology. The act of prescribing is of great ethical and technical responsibility and it must be based on scientific evidence. Thus, the patient can receive the best possible treatment, for either preventive or curative nature, by respecting the recommendations of the competent authorities and, therefore, minimizing risks and damages to patients. (AU)


Subject(s)
Humans , Female , Aged , Polyuria , Asthenia , Vitamin D/toxicity , Weight Loss , Anorexia , Ethics, Professional , Acute Kidney Injury
8.
Arch. endocrinol. metab. (Online) ; 65(4): 421-427, July-Aug. 2021. tab, graf
Article in English | LILACS | ID: biblio-1339104

ABSTRACT

ABSTRACT Objective: To evaluate the effect of beinaglutide on weight loss and plasma protein patterns of inflammation/obesity relevant cytokines and biomarkers. Materials and methods: This study involved 36 adult patients with a body mass index (BMI) of ≥ 24 kg/m2 and T2DM. Beinaglutide was administered for three months. Changes in body weight, fasting plasma glucose (FPG) level, 2 h postprandial plasma glucose (2h-PG) level, glycosylated hemoglobin (HbA1c) level, BMI and visceral and subcutaneous fat areas were measured at baseline and after three months of treatment. In addition, relevant inflammation/obesity cytokines and biomarkers were measured. Results: After three months, beinaglutide treatment led to significant changes, including in body weight, BMI, FPG level, HbA1c level, visceral and subcutaneous fat areas. In addition, serpin E1, leptin, C-reaction protein (CRP) and tumor necrosis factor-α (TNF-α) also decreased significantly. The plasma protein concentrations of CRP (Log2 transformed) were found to be positively correlated with the percentage of weight loss (R = 0.514 and p-value = 0.021). Conclusion: Beinaglutide treatment resulted in weight loss, plasma glucose control and anti-inflammatory effects in patients with T2DM and overweight/obesity.


Subject(s)
Humans , Adult , Diabetes Mellitus, Type 2/drug therapy , Blood Glucose , Weight Loss , Body Mass Index , China , Overweight/drug therapy , Obesity/drug therapy
9.
Cambios rev. méd ; 20(1): 99-106, 30 junio 2021. tabs.
Article in Spanish | LILACS | ID: biblio-1292979

ABSTRACT

En la actualidad, la obesidad es conside-rada una pandemia, cuya incidencia se ha triplicado en los últimos 30 años, y ha ge-nerado problemas de salud pública cada vez mayores. Tomando como base las guías de la Asociación Americana de Endocrinólogos (AACE), la Sociedad para la Obesidad, la Sociedad Americana de Cirugía Bariátrica y Metabólica (ASMBS), la Asociación para Medicina de la Obe-sidad y la Asociación Americana de Anes-tesiólogos, se realiza el presente docu-mento, con el fin de que se constituya en la hoja de ruta que guíe el procedimiento a seguir en los pacientes que padecen de esta enfermedad crónica y que acuden al Hospital General San Francisco (HGSF)1. La obesidad se caracteriza por el uso de varios medicamentos debido a las co-morbilidades relacionadas: enfermedad cardiovascular, diabetes mellitus tipo 2, enfermedad renal crónica, hígado graso no alcohólico, síndrome metabólico y varios tipos de cánceres2. Este protocolo contiene el más alto nivel de evidencia disponible hasta la fecha, en relación al manejo quirúrgico y no quirúrgico del paciente con diagnóstico de obesidad, incluyendo temas como la identificación de los pacientes candidatos para los pro-cedimientos bariátricos, tipo de proce-dimientos que deberían ser ofertados, el manejo preoperatorio, transoperatorio y el cuidado post operatorio de seguimiento2-4.Desde la publicación por parte de la Ame-rican Society for Metabolic and Bariatric Surgery (ASMBS) en el año 2013 de las guías de manejo del paciente con obe-sidad, se ha evidenciado un incremento significativo en las publicaciones que avalan excelentes resultados para el tra-tamiento de los pacientes con obesidad y con diabetes mellitus tipo 2 mediante la cirugía bariátrica y metabólica 2,5,6. En el año 2016 la publicación del Diabetes Sur-gery Summit (DSS2)7 marca diferencia en el manejo de los pacientes con diabetes mellitus tipo 2, es así que las mismas han crecido sustancialmente y la evidencia demuestra que el manejo metabólico ba-riátrico de estos pacientes es superior al manejo médico y cambios de estilo de vida cuando se evalúa el control glucémico y remisión de las comorbilidades. Con la evaluación previa del equipo mul-tidisciplinario, tendremos información científica del más alto nivel que nos per-mita tener un paciente con recuperación óptima aplicando los criterios de En-hanced Recovery after Bariatric Surgery (ERASB)8. En el Ecuador, la obesidad se ha conver-tido en un problema de salud pública, es así que en la población pediátrica ha au-mentado desde el año 1986 pasando del 8,0% al 26,0% para el año 2012 en el grupo de 11 a 19 años. La prevalencia de sobrepeso y obesidad en población adulta en el Ecuador es del 62,8%, según el sexo es 5,5% mayor en las mujeres (65,5%) que en los hombres (60,0%), y el mayor índice de obesidad y sobrepeso se pre-senta entre la cuarta y quinta décadas de vida, con prevalencias superiores a 73,0%9,10.


Currently, obesity is considered a pan-demic, the incidence of which has tripled in the last 30 years, and has generated in-creasing public health problems. Based on the guidelines of the American As-sociation of Endocrinologists (AACE), the Obesity Society, the American So-ciety for Metabolic and Bariatric Surgery (ASMBS), the Association for Obesity Medicine and the American Association of Anesthesiologists, this document is intended to serve as a roadmap to guide the procedure to be followed in patients suffering from this chronic disease who come to San Francisco General Hospital (HGSF)1.Obesity is characterized by the use of se-veral medications due to related comor-bidities: cardiovascular disease, type 2 diabetes mellitus, chronic kidney disease, non-alcoholic fatty liver disease, meta-bolic syndrome and several types of can-cers2. This protocol contains the highest level of evidence available to date, in relation to the surgical and non-surgical management of the patient with a diag-nosis of obesity, including issues such as the identification of candidate patients for bariatric procedures, type of proce-dures that should be offered, preopera-tive, trans-operative management and fo-llow-up post-operative care2-4.Since the publication by the American So-ciety for Metabolic and Bariatric Surgery (ASMBS) in 2013 of the guidelines for the management of patients with obesity, there has been a significant increase in publications that support excellent results for the treatment of patients with obesity and type 2 diabetes mellitus through bariatric and metabolic surgery2,5,6. In 2016 the pu-blication of the Diabetes Surgery Summit (DSS2)7 makes a difference in the mana-gement of patients with type 2 diabetes mellitus, it is so that the same have grown substantially and the evidence shows that bariatric metabolic management of these patients is superior to medical manage-ment and lifestyle changes when glycemic control and remission of comor-bidities are evaluated. With the previous evaluation of the multidisciplinary team, we will have scientific information of the highest level that will allow us to have a patient with optimal recovery applying the criteria of Enhanced Recovery after Bariatric Surgery (ERASB)8.In Ecuador, obesity has become a public health problem; thus, in the pediatric population it has increased since 1986 from 8,0% to 26,0% in 2012 in the 11 to 19 years age group. The prevalence of overweight and obesity in the adult po-pulation in Ecuador is 62,8%, according to sex is 5,5% higher in women (65,5%) than in men (60,0%), and the highest rate of obesity and overweight occurs between the fourth and fifth decades of life, with prevalences higher than 73,0%9,10.


Subject(s)
Humans , Male , Female , Bariatric Surgery , Weight Reduction Programs , Obesity Management , Nutritional and Metabolic Diseases , Obesity , Body Weight , Weight Loss , Feeding and Eating Disorders , Body Mass Index , Diet, Food, and Nutrition , Metabolism
10.
Rev. habanera cienc. méd ; 20(3): e3674, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1280438

ABSTRACT

Introducción: El Síndrome de la Arteria Mesentérica Superior es causa poco frecuente de obstrucción duodenal. Los síntomas varían desde una obstrucción leve hasta emergencias agudas. El examen físico no siempre ayuda al diagnóstico, que se basa en los hallazgos imagenológicos. Objetivo: preconizar, recomendar el uso de las técnicas mínimamente invasivas en el manejo quirúrgico del Síndrome de la Arteria Mesentérica Superior. Presentación del caso: Mujer de 49 años de edad, antecedentes de pérdida de peso después de quimioterapia con náuseas, vómitos y dolor abdominal posprandial de dos años de evolución. Tratada exitosamente con duodenoyeyunostomía laparoscópica. El tratamiento inicial suele ser conservador. Publicaciones recientes respaldan que la duodenoyeyunostomía laparoscópica es un método seguro y efectivo para su tratamiento. Conclusiones: El tratamiento quirúrgico es cada vez más exitoso, la mayoría de los pacientes no presenta síntomas después de la cirugía(AU)


Introduction: Superior Mesenteric Artery Syndrome is an uncommon cause of duodenal obstruction. Symptoms may vary from mild obstruction to acute life-threatening emergencies. Physical examination does not always help in establishing the diagnosis which is based on findings from imaging studies. Objective: To recommend the laparoscopic approach for the surgical treatment of this entity. Case presentation: A 49-year old female patient with prior history of weight loss after chemotherapy and a two-year history of postprandial nausea, vomiting, and abdominal pain who was successfully treated by laparoscopic duodenojejunostomy is presented. Discussion: Initial treatment is usually conservative. Recently published studies support that laparoscopic duodenojejunostomy is a safe and effective method of treatment. Conclusions: Surgical treatment is becoming more successful and the majority of patients are symptom-free after surgery(AU)


Subject(s)
Humans , Female , Middle Aged , Superior Mesenteric Artery Syndrome/therapy , Abdominal Pain , Drug Therapy , Duodenal Obstruction/complications , Weight Loss , Duodenoscopy/methods
11.
Rev. colomb. cir ; 36(3): 457-461, 20210000. fig
Article in Spanish | LILACS | ID: biblio-1254260

ABSTRACT

Introducción. La Organización Mundial de la Salud define la obesidad como un incremento en el porcentaje de grasa corporal, generalmente acompañado de aumento en el peso, cuya cantidad y distribución condicionan la salud del individuo. Se caracteriza por ser una enfermedad crónica y de muy difícil manejo. La cirugía bariátrica es un procedimiento cada vez más frecuente, que ha demostrado ser la mejor opción terapéutica para el manejo de la obesidad moderada y severa, enfermedad que ha ido ganado terreno en el mundo. Según la Encuesta Nacional de la Situación Nutricional en Colombia 2015, la incidencia de sobrepeso fue del 37,8 % y de obesidad del 18,7 %. Con el incremento de la cirugía bariátrica primaria, también se ha incrementado la frecuencia de la cirugía bariátrica de revisión, conversión y reversión, siendo la de conversión la más frecuente. Métodos. Estudio observacional retrospectivo en el que se analizaron los pacientes llevados a cirugía bariátrica de conversión en el Hospital Universitario San Ignacio entre 2014 y 2019. Resultados. En nuestra institución la cirugía de conversión corresponde al 8,8 %, y coincide con la estadística mundial para este procedimiento. La causa más frecuente, a diferencia de la literatura, es el reflujo gastroesofágico, seguido de la reganancia de peso. Discusión. Los resultados obtenidos en el Hospital Universitario San Ignacio se asemejan a las cifras mundiales de procedimientos de conversión. Se obtiene la resolución de los síntomas de reflujo gastroesofágico y el manejo adecuado de la reganancia de peso en un alto porcentaje de pacientes, con muy pocas complicaciones


Introduction. The World Health Organization defines obesity as an increase in the percentage of body fat, generally accompanied by an increase in weight, the quantity and distribution of which determine the health of the individual. It is characterized by being a chronic disease and very difficult to manage. Bariatric surgery is an increasingly fre-quent procedure, which has proven to be the best therapeutic option for the management of moderate and severe obesity, a disease that has been gaining ground in the world. According to the 2015 National Survey of the Nutri-tional Situation in Colombia, the incidence of overweight was 37.8% and obesity was 18.7%. With the increase in primary bariatric surgery, the frequency of revision, conversion and reversal bariatric surgery has also increased, with conversion being the most frequent.Methods. Retrospective observational study in which patients underwent bariatric conversion surgery at the San Ignacio University Hospital between 2014 and 2019 were analyzed.Results. In our institution, conversion surgery corresponds to 8.8%, and coincides with the world statistics for this procedure. The most frequent cause, unlike the literature, is gastroesophageal reflux, followed by weight gain.Discussion. The results obtained at the San Ignacio University Hospital are similar to the world figures for con-version procedures. Resolution of gastroesophageal reflux symptoms and proper management of weight gain are obtained in a high percentage of patients, with very few complications


Subject(s)
Humans , Bariatric Surgery , Obesity , Weight Loss , Gastroesophageal Reflux
12.
Arch. argent. pediatr ; 119(2): e171-e175, abril 2021. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1152122

ABSTRACT

Los tumores del sistema nervioso central representan la segunda enfermedad oncológica más habitual en niños y adolescentes. Entre los tumores intracraneales, los de células germinales son infrecuentes. Los síntomas que desencadenan son cefalea, náuseas, vómitos, déficits hormonales, alteraciones visuales, pérdida de peso, pobre crecimiento y pubertad precoz. Menos frecuentemente, producen trastornos del movimiento o psiquiátricos. Algunos de estos tumores pueden ser asintomáticos un largo período, lo que desencadena un diagnóstico tardío.Se presenta a una paciente femenina de 14 años con pérdida de peso y falla del crecimiento, con diagnóstico erróneo de trastorno de la conducta alimentaria. Tras estudios pertinentes, se arribó al diagnóstico de germinoma del sistema nervioso central. Al ser esta patología infrecuente y de presentación variable, requiere alto sentido de alerta por parte de la familia involucrada y del equipo de salud para evitar retrasos en el diagnóstico y el tratamiento


Central nervous system tumors are the second most frequent oncological disease among children and teenagers. Among the intracranial tumors, the germ cells ones are infrequent. The symptoms they cause are headaches, nausea and vomiting, hormonal deficits, visual disturbances, weight loss, poor growth and early puberty. Less frequently, they produce movement or psychiatric disorders. Some of these tumors can be asymptomatic for a long period leading to a late diagnosis.The case of a 14-year-old female patient is presented. She showed weight loss and growth failure, with wrong diagnosis of eating disorder. After proper study methods, we arrived to central nervous system germinoma diagnosis. Because this pathology is rare and has a variable form of presentation, it requires that the family involved and the health team to be alert, to avoid delays in diagnosis and treatment.


Subject(s)
Humans , Female , Adolescent , Germinoma/diagnostic imaging , Brain Neoplasms , Weight Loss , Germinoma/therapy , Failure to Thrive , Hypopituitarism
13.
Rev. colomb. gastroenterol ; 36(supl.1): 91-97, abr. 2021. graf
Article in Spanish | LILACS | ID: biblio-1251554

ABSTRACT

Resumen Los pacientes con dermatomiositis presentan un mayor riesgo de asociación con patología maligna subyacente, sin conocerse una causa precisa de esta relación. Son múltiples las posibles localizaciones anatómicas, entre las que se incluyen los ovarios, mamas, zona gástrica, zona colorrectal, sangre, pulmones y próstata. Se presenta el caso de una mujer de 58 años que durante el estudio de pérdida anormal de peso manifestó debilidad muscular grave y alteraciones dermatológicas asociadas con el hallazgo de adenocarcinoma del colon transverso.


Abstract Patients with dermatomyositis are more likely to have an underlying malignancy, although the exact cause of this association is unknown. There are multiple possible anatomical sites, including ovaries, breasts, stomach, colorectum, blood, lungs, and prostate. We present the case of a 58-year-old woman who during abnormal weight loss study showed severe muscle weakness and skin alterations, associated with finding of adenocarcinoma of the transverse colon.


Subject(s)
Humans , Female , Middle Aged , Colorectal Neoplasms , Colon, Transverse , Dermatomyositis , Skin , Weight Loss , Literature
14.
Article in Chinese | WPRIM | ID: wpr-877670

ABSTRACT

OBJECTIVE@#To explore the impacts on weight reduction effect treated with acupoint thread embedding therapy at different tissue levels under ultrasonic guidance.@*METHODS@#A total of 70 patients with overweight or obesity were randomized into a shallow-tissue thread embedding group (35 cases, 5 cases dropped off) and a deep-tissue thread embedding group (35 cases, 4 cases dropped off). Under ultrasonic guidance, the thread was embedded in the shallow tissue level and the deep tissue level respectively. The acupoints were Zhongwan (CV 12), Xiawan (CV 10), Shuifen (CV 9), Zhongji (CV 3), etc. The thread embedding therapy was exerted once every 2 weeks, totally for 3 times. Before and 2 weeks after treatment, body mass, body mass index (BMI), waist circumference and hip circumference were recorded in the patients of the two groups separately. After each treatment, the number and the property of blood vessels under each acupoint were detected by ultrasound. Besides, the needling sensation and the intensity were scored and the adverse events were observed after thread embedding therapy.@*RESULTS@#After treatment, the reduction range of body mass, BMI and waist circumference in the deep-tissue thread embedding group were larger than those in the shallow-tissue thread embedding group successively (@*CONCLUSION@#The deep-tissue thread embedding therapy achieves the stronger


Subject(s)
Acupuncture Points , Acupuncture Therapy , Body Mass Index , Catgut , Humans , Ultrasonics , Weight Loss
15.
Frontiers of Medicine ; (4): 460-471, 2021.
Article in English | WPRIM | ID: wpr-888754

ABSTRACT

Lifestyle interventions, including dietary adjustments and exercise, are important for obesity management. This study enrolled adults with overweight or obesity to explore whether either low-carbohydrate diet (LCD) or exercise is more effective in metabolism improvement. Forty-five eligible subjects were randomly divided into an LCD group (n = 22) and an exercise group (EX, n = 23). The subjects either adopted LCD (carbohydrate intake < 50 g/day) or performed moderate-to-vigorous exercise (⩾ 30 min/day) for 3 weeks. After the interventions, LCD led to a larger weight loss than EX ( - 3.56 ± 0.37 kg vs. - 1.24 ± 0.39 kg, P < 0.001), as well as a larger reduction in fat mass ( - 2.10 ± 0.18 kg vs. - 1.25 ± 0.24 kg, P = 0.007) and waist circumference ( - 5.25 ± 0.52 cm vs. - 3.45 ± 0.38 cm, P = 0.008). Both interventions reduced visceral and subcutaneous fat and improved liver steatosis and insulin resistance. Triglycerides decreased in both two groups, whereas low-density lipoprotein cholesterol increased in the LCD group but decreased in the EX group. Various glycemic parameters, including serum glycated albumin, mean sensor glucose, coefficient of variability (CV), and largest amplitude of glycemic excursions, substantially declined in the LCD group. Only CV slightly decreased after exercise. This pilot study suggested that the effects of LCD and exercise are similar in alleviating liver steatosis and insulin resistance. Compared with exercise, LCD might be more efficient for weight loss and glucose homeostasis in people with obesity.


Subject(s)
Adult , Blood Glucose , Diet, Carbohydrate-Restricted , Homeostasis , Humans , Pilot Projects , Weight Loss
16.
Acta cir. bras ; 36(2): e360203, 2021. tab, graf
Article in English | LILACS | ID: biblio-1152702

ABSTRACT

ABSTRACT Purpose To analyze the effectiveness of vertical gastrectomy in the treatment of obese patients, adherence to clinical follow-up and the influence of factors such as gender and age. Methods This is a retrospective, observational and descriptive study, conducted with patients undergoing vertical gastrectomy, operated at Hospital São Domingos, between January 2016 and July 2018. Results Most patients undergoing vertical gastrectomy were female (n = 193, 72.28%) and had a mean age of37.11 ± 8.96 years old. The loss of follow-up was 56.18%. Among adherent patients (n = 117; 43.82%), most patients were female (n = 89; 76.07%) and had a mean age of 37.92 ± 9.85 years old. The mean body mass index (BMI) of the adherents in the preoperative was 37.85 ± 3.72 kg/m2. Both BMI and excess weight (EW) showed a statistically significant difference between pre- and postoperative period. Percentage of excess weight loss (% EWL) was satisfactory for 96.6% of adherent patients. Older patients had a statistically significant lower % EWL compared to the other groups. Conclusions Vertical gastrectomy was effective in the treatment of obese patients, with significant weight loss.


Subject(s)
Humans , Female , Adult , Weight Loss , Gastrectomy , Postoperative Period , Retrospective Studies , Follow-Up Studies , Middle Aged , Obesity/surgery
17.
Psicol. ciênc. prof ; 41: e222795, 2021. graf
Article in Portuguese | LILACS, INDEXPSI | ID: biblio-1346799

ABSTRACT

A alimentação, as práticas de emagrecimento e a cirurgia bariátrica são temas estudados em diferentes concepções, em interface entre as áreas das ciências humanas e da saúde. Este estudo propõe uma aproximação da teoria das Representações Sociais às complexas implicações das práticas de saúde adotadas por pessoas obesas frente aos padrões de beleza socialmente impostos. Objetivou-se compreender as Representações Sociais da alimentação e da cirurgia bariátrica entre 16 pessoas obesas de idades entre 20 e 58 anos e Índice de Massa Corporal (IMC) médio de 38,3kg/m2, com as quais foram realizadas entrevistas com questões abertas sobre a alimentação e a cirurgia bariátrica. Os dados foram analisados por Classificação Hierárquica Descendente por meio do programa IRaMuTeQ. Os resultados indicam que a alimentação assume representações sociais ambíguas, ora voltadas ao prazer ora ao sofrimento pela dificuldade de controle. Quando a obesidade se instala, a cirurgia bariátrica surge como esperança definitiva para a solução dos problemas, além de suscitar, mas, além da esperança, experencia-se também o medo do fracasso e das mudanças decorrentes da intervenção cirúrgica.(AU)


Food, weight loss practices, and bariatric surgery are themes studied under different conceptions on both the fields of the humanities and health. This study aims to approximate the theory of social representations to the implications of health practices adopted by obese people in view of the socially-imposed beauty standards. To understand the Social Representations of food and bariatric surgery, open-questions interviews about eating habits and bariatric surgery were conducted with 16 obese people aged between 20 and 58 years with mean body mass index of 38.3 kg / m2. Data were analyzed by descending hierarchical classification using the IRaMuTeQ program. The results indicate that food has ambiguous social representations, at times related to pleasure and at others to suffering due to the difficulty of control. When obesity sets in, bariatric surgery emerges as the ultimate hope for solving problems; however, along with hope, individuals experience the fear of failure and changes resulting from the surgical intervention.(AU)


La alimentación, las prácticas de adelgazamiento y la cirugía bariátrica son temas abordados en las áreas de las humanidades y la salud desde diferentes enfoques. Este estudio propone una aproximación de la teoría de las representaciones sociales a las complejas implicaciones de las prácticas de salud adoptadas por las personas obesas ante los estándares de belleza impuestos por la sociedad. Su propósito fue comprender las representaciones sociales de la cirugía alimentaria y bariátrica de 16 personas obesas, con edades entre 20 y 58 años e índice de masa corporal (IMC) promedio de 38,3 kg/m2; las cuales participaron de entrevistas con preguntas abiertas sobre la alimentación y la cirugía bariátrica. Los datos se analizaron por clasificación jerárquica descendente utilizando el programa IRaMuTeQ. Los resultados indican que los alimentos tienen representaciones sociales ambiguas, que a veces se convierten en placer y, otras, en sufrimiento debido a la dificultad de control. Cuando la obesidad se instala, la cirugía bariátrica se vuelve una ilusión definitiva como la solución de los problemas, junto con el miedo al fracaso y los cambios resultantes de esta intervención quirúrgica.(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Young Adult , Reference Standards , Weight Loss , Feeding and Eating Disorders , Bariatric Surgery , Feeding Behavior , Psychology , Surgical Procedures, Operative , Beauty , Body Mass Index , Health , Food , Obesity
19.
ABCD arq. bras. cir. dig ; 34(4): e1634, 2021. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1360005

ABSTRACT

RESUMO - RACIONAL: Os fatores relacionados à perda de peso nos pacientes obesos submetidos à cirurgia bariátrica sempre foram exaustivamente estudados na tentativa de propor a melhor técnica cirúrgica com maior perda de peso e resolução as comorbidades à longo prazo. Os pacientes apresentam variações anatômicas no que tange o comprimento do intestino delgado. Há estudos que demonstram alterações de peso nos pacientes que apresentam diferentes comprimentos das alças intestinais na técnica do by-pass em Y de Roux. O presente trabalho realizou um estudo entre a influência do IMC, a perda de peso e o comprimento da alça comum nos resultados cirúrgicos à longo prazo. MÉTODOS: Estudo transversal descritivo pela análise retrospectiva de 112 prontuários de pacientes submetidos à cirurgia bariátrica aberta pela técnica do bypass gástrico no Hospital de Clínicas -UFPR. Os dados foram correlacionados em programas estatísticos para este fim. RESULTADOS: Dos 112 pacientes, 83,03% eram do sexo feminino, média de idade de 41,52 anos. O comprimento médio do intestino delgado total dos pacientes foi de 5,02 metros. Houve uma relação diretamente proporcional entre o comprimento do intestino delgado e a perda de peso (p=0,0428). CONCLUSÃO: Há uma ampla gama de variáveis relacionadas à perda de peso nos pacientes submetidos à cirurgia bariátrica, tais como a técnica utilizada, o comprimento das alças no by-pass gástrico em Y de Roux e a rotina de acompanhamento nutricional e físico do paciente. É importante considerar os detalhes técnicos do procedimento cirúrgico, e verificar a perda de peso avaliando-se o paciente como um todo e outras variáveis.


ABSTRACT - BACKGROUND: Factors related to weight loss in obese patients undergoing bariatric surgery have always been exhaustively studied in an attempt to propose the best surgical technique with greater weight loss and long-term resolution of comorbidities. Patients present anatomical variations regarding the length of the small intestine. Some studies demonstrate weight changes in patients with different lengths of the intestinal loops in the Roux-en-Y bypass technique. The present work carried out a study on the influence of body mass index, weight loss, and common loop length on long-term surgical outcomes. METHODS: This is a descriptive cross-sectional study by retrospective analysis of 112 medical records of patients undergoing open bariatric surgery using the gastric bypass technique at University Hospital - UFPR. The data were correlated in statistical programs for this purpose. RESULTS: Out of 112 patients, 83.03% were women, with mean age of 41.52 years. The mean length of the total small bowel of the patients was 5.02 m. There was a directly proportional relationship between the length of the small intestine and weight loss (p=0.0428). CONCLUSION: There is a wide range of variables related to weight loss in patients undergoing bariatric surgery, such as the technique used, the length of the loops in the Roux-en-Y gastric bypass, and the routine of nutritional and physical monitoring of the patient. It is important to assess the technical details of the surgical procedure and to verify the weight loss by evaluating integrally the patient and other variables.


Subject(s)
Humans , Female , Adult , Obesity, Morbid , Weight Loss , Cross-Sectional Studies , Retrospective Studies , Intestine, Small/surgery
20.
ABCD arq. bras. cir. dig ; 34(2): e1602, 2021. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1345018

ABSTRACT

ABSTRACT Background: Morbid obesity surgery and related complications have increased with time. Aim: To evaluate the relationship between perioperative complications before discharge and preoperative body mass index and obesity surgery mortality score in laparoscopic sleeve gastrectomy. Method: 1617 patients who met the inclusion criteria were evaluated retrospectively. The patients were examined in terms of demographic data, presence of comorbidities, whether there were complications or not, type of complications and obesity surgery mortality score. Results: Complications were seen in 40 patients (2.5%) and mortality wasn't seen in the early postoperative period before discharge. The mean age of patients with complications was 36.3±10.02 years (19-57) and without complications 34.12±9.54 (15-64) years. The preoperative mean BMI values of patients with and without complications were 45.05±3.93 (40-57) kg/m2 and 44.8±3.49 (35-67) kg/m2 respectively. According to BMI groups 40-45 kg/m2, 45-50 kg/m2 and 50 and over, there was not any statistical significance seen in three groups in terms of complication positivity and major-minor complication rates. There was not any statistical significance seen between the patients with and without major-minor complications and obesity surgery mortality score. Conclusion: There was not any relation between perioperative laparoscopic sleeve gastrectomy complication rates before discharge and BMI and obesity surgery mortality scores.


RESUMO Racional: A cirurgia da obesidade mórbida e complicações relacionadas aumentaram com o tempo. Objetivo: Avaliar a relação entre as complicações perioperatórias antes da alta e o índice de massa corporal pré-operatório e o escore de mortalidade da cirurgia de obesidade na gastrectomia vertical laparoscópica. Método: 1.617 pacientes que atenderam aos critérios de inclusão foram avaliados retrospectivamente. Os pacientes foram examinados quanto aos dados demográficos, presença de comorbidades, ocorrência ou não de complicações, tipo de complicações e escore de mortalidade cirúrgico da obesidade. Resultados: Complicações foram observadas em 40 pacientes (2,5%) e mortalidade não foi observada no período pós-operatório imediato antes da alta. A média de idade dos pacientes com complicações foi de 36,3±10,02 anos (19-57) e sem complicações de 34,12±9,54 (15-64) anos. Os valores médios de IMC pré-operatórios dos pacientes com e sem complicações foram 45,05±3,93 (40-57) kg/m2 e 44,8±3,49 (35-67) kg/m2, respectivamente. De acordo com os grupos de IMC 40-45 kg/m2, 45-50 kg/m2 e 50 e mais, não houve qualquer significância estatística observada em três grupos em termos de positividade de complicações e taxas de complicações maiores-menores. Não houve significância estatística entre os pacientes com e sem complicações maiores e menores e o escore de mortalidade da cirurgia de obesidade. Conclusão: Não houve qualquer relação entre as taxas de complicações da gastrectomia vertical laparoscópica perioperatória antes da alta e os escores de mortalidade da cirurgia de obesidade e IMC.


Subject(s)
Humans , Adult , Young Adult , Obesity, Morbid/surgery , Laparoscopy , Patient Discharge , Postoperative Complications/epidemiology , Weight Loss , Body Mass Index , Retrospective Studies , Follow-Up Studies , Treatment Outcome , Gastrectomy/adverse effects , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL